Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unrelated HSCT in Patients With Fanconi Anemia
NCT02127905Withdrawn
- Start
- Mar 2011
- Primary completion
- Mar 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of CD34+ selected donor cells in Fanconi anemia (FA). Primary endpoint: Event free survival post stem cell transplant at 5 years. Planned start Mar 2011; status: withdrawn.
02
Drugs
CD34+ selected donor cells
03
Conditions
Fanconi anemia (FA)
Beyond the preview
Go deeper on NCT02127905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02127905.